<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Viruses</journal-id>
    <journal-id journal-id-type="iso-abbrev">Viruses</journal-id>
    <journal-id journal-id-type="publisher-id">viruses</journal-id>
    <journal-title-group>
      <journal-title>Viruses</journal-title>
    </journal-title-group>
    <issn pub-type="epub">1999-4915</issn>
    <publisher>
      <publisher-name>MDPI</publisher-name>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6784143</article-id>
    <article-id pub-id-type="doi">10.3390/v11090806</article-id>
    <article-id pub-id-type="publisher-id">viruses-11-00806</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>MiDRM<italic>pol</italic>: A High-Throughput Multiplexed Amplicon Sequencing Workflow to Quantify HIV-1 Drug Resistance Mutations against Protease, Reverse Transcriptase, and Integrase Inhibitors</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Aralaguppe</surname>
          <given-names>Shambhu G.</given-names>
        </name>
        <xref ref-type="aff" rid="af1-viruses-11-00806">1</xref>
        <xref rid="c1-viruses-11-00806" ref-type="corresp">*</xref>
        <xref ref-type="author-notes" rid="fn1-viruses-11-00806">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Ambikan</surname>
          <given-names>Anoop T.</given-names>
        </name>
        <xref ref-type="aff" rid="af1-viruses-11-00806">1</xref>
        <xref ref-type="author-notes" rid="fn1-viruses-11-00806">†</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-7880-9497</contrib-id>
        <name>
          <surname>Ashokkumar</surname>
          <given-names>Manickam</given-names>
        </name>
        <xref ref-type="aff" rid="af1-viruses-11-00806">1</xref>
        <xref ref-type="aff" rid="af2-viruses-11-00806">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Kumar</surname>
          <given-names>Milner M.</given-names>
        </name>
        <xref ref-type="aff" rid="af3-viruses-11-00806">3</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Hanna</surname>
          <given-names>Luke Elizabeth</given-names>
        </name>
        <xref ref-type="aff" rid="af2-viruses-11-00806">2</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-4950-3966</contrib-id>
        <name>
          <surname>Amogne</surname>
          <given-names>Wondwossen</given-names>
        </name>
        <xref ref-type="aff" rid="af4-viruses-11-00806">4</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Sönnerborg</surname>
          <given-names>Anders</given-names>
        </name>
        <xref ref-type="aff" rid="af1-viruses-11-00806">1</xref>
        <xref ref-type="aff" rid="af5-viruses-11-00806">5</xref>
      </contrib>
      <contrib contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-0844-3338</contrib-id>
        <name>
          <surname>Neogi</surname>
          <given-names>Ujjwal</given-names>
        </name>
        <xref ref-type="aff" rid="af1-viruses-11-00806">1</xref>
      </contrib>
    </contrib-group>
    <aff id="af1-viruses-11-00806"><label>1</label>Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, 14186 Stockholm, Sweden</aff>
    <aff id="af2-viruses-11-00806"><label>2</label>Department of HIV/AIDS, National Institute for Research in Tuberculosis, Indian Council of Medical Research, Chennai 600031, India</aff>
    <aff id="af3-viruses-11-00806"><label>3</label>Blackbuck Technologies, Porur, Chennai 600116, India</aff>
    <aff id="af4-viruses-11-00806"><label>4</label>Department of Internal Medicine, School of Medicine, Addis Ababa University, 2380 Addis Ababa, Ethiopia</aff>
    <aff id="af5-viruses-11-00806"><label>5</label>Division of Infectious Diseases, Department of Medicine Huddinge, Karolinska Institutet, 14186 Stockholm, Sweden</aff>
    <author-notes>
      <corresp id="c1-viruses-11-00806"><label>*</label>Correspondence: <email>shambhu.aralaguppe@gmail.com</email> or <email>shambhu.aralaguppe@ki.se</email></corresp>
      <fn id="fn1-viruses-11-00806">
        <label>†</label>
        <p>Equal contribution.</p>
      </fn>
    </author-notes>
    <pub-date pub-type="epub">
      <day>30</day>
      <month>8</month>
      <year>2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <month>9</month>
      <year>2019</year>
    </pub-date>
    <volume>11</volume>
    <issue>9</issue>
    <elocation-id>806</elocation-id>
    <history>
      <date date-type="received">
        <day>15</day>
        <month>8</month>
        <year>2019</year>
      </date>
      <date date-type="accepted">
        <day>24</day>
        <month>8</month>
        <year>2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2019 by the authors.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <license license-type="open-access">
        <license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p>
      </license>
    </permissions>
    <abstract>
      <p>The detection of drug resistance mutations (DRMs) in minor viral populations is of potential clinical importance. However, sophisticated computational infrastructure and competence for analysis of high-throughput sequencing (HTS) data lack at most diagnostic laboratories. Thus, we have proposed a new pipeline, MiDRM<italic>pol</italic>, to quantify DRM from the HIV-1 <italic>pol</italic> region. The gag-vpu region of 87 plasma samples from HIV-infected individuals from three cohorts was amplified and sequenced by Illumina HiSeq2500. The sequence reads were adapter-trimmed, followed by analysis using in-house scripts. Samples from Swedish and Ethiopian cohorts were also sequenced by Sanger sequencing. The pipeline was validated against the online tool PASeq (Polymorphism Analysis by Sequencing). Based on an error rate of &lt;1%, a value of &gt;1% was set as reliable to consider a minor variant. Both pipelines detected the mutations in the dominant viral populations, while discrepancies were observed in minor viral populations. In five HIV-1 subtype C samples, minor mutations were detected at the &lt;5% level by MiDRM<italic>pol</italic> but not by PASeq. MiDRM<italic>pol</italic> is a computationally as well as labor efficient bioinformatics pipeline for the detection of DRM from HTS data. It identifies minor viral populations (&lt;20%) of DRMs. Our method can be incorporated into large-scale surveillance of HIV-1 DRM. </p>
    </abstract>
    <kwd-group>
      <kwd>MiDRM<italic>pol</italic></kwd>
      <kwd>high-throughput sequencing</kwd>
      <kwd>drug resistance mutation</kwd>
      <kwd>antiretroviral therapy</kwd>
      <kwd>surveillance</kwd>
    </kwd-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro" id="sec1-viruses-11-00806">
    <title>1. Introduction</title>
    <p>Genotypic resistance testing (GRT) to monitor antiretroviral therapy (ART) of human immunodeficiency virus type 1 (HIV-1) infection is challenging due to drug resistance mutations (DRMs) in minor viral populations not detected by Sanger sequencing, although the impact of such DRMs on clinical outcome is still under debate [<xref rid="B1-viruses-11-00806" ref-type="bibr">1</xref>]. A major challenge for the implementation of high-throughput sequencing (HTS) in clinical practice is the need of bioinformatics expertise, since there is still no consensus on the standardization of an efficient and easy pipeline for data analysis. However, advances in HTS technology have facilitated sufficient throughput data and sensitivity to detect very rare viral DRMs [<xref rid="B2-viruses-11-00806" ref-type="bibr">2</xref>]. On the other hand, HTS-based GRT has a few limitations that need to be addressed, including short and error-prone reads [<xref rid="B2-viruses-11-00806" ref-type="bibr">2</xref>], low-abundance interpretation of variant data, and a lack of standardization of data analysis protocols/pipelines [<xref rid="B3-viruses-11-00806" ref-type="bibr">3</xref>]. </p>
    <p>In this study, we evaluated a simplified bioinformatics pipeline, named MiDRM<italic>pol</italic>, for analysis of HTS data which is cost, labor, and computationally efficient. The Fastq files generated by HTS can be used as input to get easily inferable diagnostic reports and can be applied in large-scale surveillance. It can be used without prior knowledge of HTS or bioinformatics. Here, we restricted the analysis of DRMs to the <italic>pol</italic> region of the HIV-1 genome, including the targets of the vast majority of presently approved HIV-1 drugs: the reverse transcriptase, protease, and integrase.</p>
  </sec>
  <sec id="sec2-viruses-11-00806">
    <title>2. Materials and Methods </title>
    <sec id="sec2dot1-viruses-11-00806">
      <title>2.1. Clinical Specimens, Plasmids, and Control Virus</title>
      <p>Plasma samples were obtained from three cohorts originating from Sweden (<italic>n</italic> = 60), India (<italic>n</italic> = 10), and Ethiopia (<italic>n</italic> = 17). All patients were treatment naïve except 10 Swedish subjects, of whom only 2 were given ART at the time of plasma sampling. The majority (30/50; 60%) of the Swedish treatment-naïve subjects had been infected outside the country. Eight of the 10 Indian samples were from children who were infected through mother-to-child transmission (MTCT). Besides, to deduce the reliability of the method, a standard molecular clone (pMJ4) [<xref rid="B4-viruses-11-00806" ref-type="bibr">4</xref>] was used as described in [<xref rid="B5-viruses-11-00806" ref-type="bibr">5</xref>]. </p>
    </sec>
    <sec id="sec2dot2-viruses-11-00806">
      <title>2.2. High-Throughput Sequencing</title>
      <p>The cDNA was prepared using gene-specific primers and the HTS was carried out as described by us [<xref rid="B5-viruses-11-00806" ref-type="bibr">5</xref>]. The F1 fragment (<italic>Gag-to-vpu)</italic> (HXB2, 790-6231) was amplified and gel-purified using the QIAamp gel extraction kit (Qiagen, Venlo, The Netherlands). Briefly, the purified amplicon was fragmented on the Covaris S200 at 300 bp for 75 s with peak power-50 and cycle/burst-200, and the library was prepared using NEBNext<sup>®</sup> Ultra™ DNA Library Prep Kit for Illumina<sup>®</sup> (New England Biolabs, Ipswich, MA, USA) with multiplexed NEB next adaptors. The samples were then pooled together in sets of 48 samples along with other unrelated nonviral indexed libraries. Paired-end sequences of read length 250 bp were carried out on the Illumina HiSeq2500. </p>
    </sec>
    <sec id="sec2dot3-viruses-11-00806">
      <title>2.3. Bioinformatics Pipeline for Analysis</title>
      <p>The raw reads were adapter-trimmed using the Cutadapt v1.8 program using the default setting (error rate of &lt;0.1) [<xref rid="B6-viruses-11-00806" ref-type="bibr">6</xref>], followed by removal of the low-quality bases (Phred value score of &lt;Q30) by Sickle version 1.33 [<xref rid="B7-viruses-11-00806" ref-type="bibr">7</xref>]. Duplicate reads were removed using FastUniq [<xref rid="B8-viruses-11-00806" ref-type="bibr">8</xref>]. The processed reads were aligned against the gene nucleotide sequence of POL from HIV. This alignment was performed in local mode using Bowtie2 [<xref rid="B9-viruses-11-00806" ref-type="bibr">9</xref>] to identify reads originating from the POL gene. Then, these reads were further aligned with the POL protein sequence using the blastx program from Blast package [<xref rid="B10-viruses-11-00806" ref-type="bibr">10</xref>]. For each read, the best blast hit was chosen and all amino acid substitutions were counted. Though there were multiple amino acid substitutions at each position in the POL protein sequence, only the most-frequent substitution was considered, and the fraction of the most-frequent amino acid substitution was estimated. The complete script is available at GitHub at <uri xlink:href="https://github.com/neogilab/MiDRMPol">https://github.com/neogilab/MiDRMPol</uri>.</p>
    </sec>
    <sec id="sec2dot4-viruses-11-00806">
      <title>2.4. Standard Population Sequencing</title>
      <p>The <italic>ViroSeq</italic> HIV-1 genotyping system had been used for the Swedish patients as a part of routine clinical practice. HIV-1 GRT by population sequencing (GRT-PS) was also performed for the Ethiopian patients using an in-house method [<xref rid="B11-viruses-11-00806" ref-type="bibr">11</xref>] but not for Indian patients due to insufficient sample availability. </p>
    </sec>
    <sec id="sec2dot5-viruses-11-00806">
      <title>2.5. HIV-1 Subtyping and Phylogenetic Analysis</title>
      <p>Consensus <italic>pol</italic> sequences were generated from the base count data with the occurrence of a particular nucleotide of &gt;50% in a given position and subtyped by REGAv3 [<xref rid="B12-viruses-11-00806" ref-type="bibr">12</xref>] and COMET-HIV [<xref rid="B13-viruses-11-00806" ref-type="bibr">13</xref>], followed by phylogenetic analysis using MEGA7.</p>
    </sec>
    <sec id="sec2dot6-viruses-11-00806">
      <title>2.6. Drug Resistance Mutations</title>
      <p>For treatment-naïve individuals, DRMs was described using definitions for surveillance of transmitted HIV-1 drug resistance, 2009 Update (sDRM2009) [<xref rid="B14-viruses-11-00806" ref-type="bibr">14</xref>]. Mutation lists provided in the Stanford University HIV Drug Resistance Database [<xref rid="B15-viruses-11-00806" ref-type="bibr">15</xref>], accessed on 6 January 2018 [<xref rid="B15-viruses-11-00806" ref-type="bibr">15</xref>,<xref rid="B16-viruses-11-00806" ref-type="bibr">16</xref>], was used for describing major integrase mutations, including Q148H, E138K, T66I, and Q148H. The DRMs of treatment-experienced patients were interpreted based on the Stanford University HIV Drug Resistance Database [<xref rid="B15-viruses-11-00806" ref-type="bibr">15</xref>].</p>
    </sec>
    <sec id="sec2dot7-viruses-11-00806">
      <title>2.7. Availability of Data</title>
      <p>The GenBank IDs for the sequences are available with the following accession numbers: for the Indian cohort: KX069219-228; for the Swedish cohort: MF373124-206; and for the Ethiopian cohort: KP411823-826, 828 and KP411830-845. Fastq files: Submission ID: SUB5359871, BioProject ID: PRJNA529776.</p>
    </sec>
    <sec id="sec2dot8-viruses-11-00806" sec-type="subjects">
      <title>2.8. Ethics Approval and Consent of Participants</title>
      <p>Ethical permissions were obtained from the respective sites. Swedish samples: Regional Ethics Committee Stockholm (Dnr: 2006/1367-31/4); Ethiopian samples: the Ethiopian Science and Technology Agency (Ref. No. RPHE/126-83/08), and the Drug Administration and Control Authority of Ethiopia (Ref. No. 02/6/22/17); Indian samples: National Institute for Research in Tuberculosis Institutional Ethics Committee (NIRT IEC No. 2009009). The patients’ information was anonymized and delinked before analysis. </p>
    </sec>
  </sec>
  <sec sec-type="results" id="sec3-viruses-11-00806">
    <title>3. Results</title>
    <sec id="sec3dot1-viruses-11-00806">
      <title>3.1. Coverage and Error Rate</title>
      <p>The amino acid coverage at each postion of the HIV-pol region was calculated in terms of quartiles. The range of first quartile was 3836x–12,725x whereas for third quartile, it was 15,403×–36,451x. All the DRM positions had median coverage &gt;5000x (<xref ref-type="fig" rid="viruses-11-00806-f001">Figure 1</xref>a). To estimate the intrinsic error introduced by the laboratory workflow, we sequenced pMJ4, where the error rate was found to be &lt;1% at the nucleotide level [<xref rid="B5-viruses-11-00806" ref-type="bibr">5</xref>]. In addition, we determined the median error rate at the amino acid level, which was 0.2% (0–1.8%) (<xref ref-type="fig" rid="viruses-11-00806-f001">Figure 1</xref>b).</p>
    </sec>
    <sec id="sec3dot2-viruses-11-00806">
      <title>3.2. Subtyping and Phylogenetic Analysis</title>
      <p>Based on the phylogenetic analysis, we found that the majority of the viral isolates (<italic>n</italic> = 78, 90%) were subtype C, of which 10 isolates were from treatment-experienced individuals. Seven (8%) isolates were subtype B. In addition, we identified one HIV-1A1 and one 01_AE. No cross contamination was found (<xref ref-type="fig" rid="viruses-11-00806-f002">Figure 2</xref>). Two Swedish samples (SE70 and SE73) clustered together and were epidemiologically linked.</p>
    </sec>
    <sec id="sec3dot3-viruses-11-00806">
      <title>3.3. Identification of DRM by GRT-HTS</title>
      <p>DRMs were identified and quantified in 23/87 patients (<xref rid="viruses-11-00806-t001" ref-type="table">Table 1</xref>). In the Swedish cohort, 9/50 (18%) therapy-naïve patients had DRMs (M46I: <italic>n</italic> = 3) (M184I, T215S, or K219R: <italic>n</italic> = 3); major--integrase strand transfer inhibitors (INSTI) mutation Q148H or E138K: <italic>n</italic> = 2)). Among Indian patients, 5/10 (50%) had reverse transcriptase inhibitors (RTI) DRM, and all 5 were MTCT patients. No DRMs were detected in horizontally infected patients. Among Ethiopian patients, 6/17 (35%) had DRMs, of whom 5 had a single-class DRM and one had both nucleoside reverse transcriptase inhibitors (NRTI) (M184I) and INSTI (Q148H) DRM.</p>
      <p>Among the 10 treatment-experienced patients from the Swedish cohort, only two patients were on ART at the time of plasma sampling, although they had high viral RNA levels, indicating that they did not take the drugs and no DRMs were found. In three patients, DRMs were found. One patient (SE03; HIV-1C) who had terminated nevirapine, tenofovir, and raltegravir therapy one month earlier had D67G and L74I. This patient had earlier been given abacavir-containing therapy. Patients SE70 and SE73 (HIV-1C) had stopped cART ABC + DDI + EFV and d4T + 3TC + NVP, respectively, a few months before plasma sampling. These subjects were epidemiologically linked and were identified with the same set of RTI mutations: D67N, L210W, T215Y, K103N, and G190A.</p>
    </sec>
    <sec id="sec3dot4-viruses-11-00806">
      <title>3.4. Comparison of DRM Detected by GRT-PS and GRT-HTS</title>
      <p>While comparing GRT-PS and GRT-HTS among the Swedish and Ethiopian patients, additional DRMs were detected by GRT-HTS (<xref rid="viruses-11-00806-t001" ref-type="table">Table 1</xref>). Among the treatment-naïve individuals (<italic>n</italic> = 77), GRT-HTS detected DRMs in 26% (20/77) of the samples (e.g., M184I (<italic>n</italic> = 4), T125S (<italic>n</italic> = 1), and M230L (<italic>n</italic> = 1)), whereas GRT-PS detected them in only one naïve patient (M230L). </p>
      <p>In treatment-experienced patients (<italic>n</italic> = 10), DRMs were detected in two and three samples by GRT-PS and GRT-HTS, respectively. In one sample (SE73), Y188YC was detected by GRT-PS and not by GRT-HTS. One of the Indian MTCT samples (IN07) had several major NRTI and NNRTI DRMs at frequencies of &lt;20%. GRT-HTS also identified major INSTI mutations at low frequencies (e.g., Q148H, E138K, and T66I), which were undetectable by GRT-PS. In two samples (SE73 and SE31), GRT-PS did not detect DRMs which were &gt;20%. </p>
      <p>When comparing MiDRM<italic>pol</italic> and PASeq outputs for 23 samples, the same DRMs with comparable frequencies were reported for 13 sequences (<xref rid="viruses-11-00806-t001" ref-type="table">Table 1</xref>). In six samples (SE03, SE07, ET115, ET122, ET159, and ET171), only MiDRM<italic>pol</italic> reported minor DRMs (frequency: 1.0%–4.8%). In four samples, PASeq did not deliver results due to the large file size (the file upload limit of PASeq is 1 GB). </p>
      <p>In detail, the discrepancy was due to M184I (1.0%–1.5%), which is considered to be a DRM in MiDRM<italic>pol</italic> but not in PASeq, in three samples (ET115, ET159, and ET171). In sample SE03, D67G and L74I (2.0% and 1.9%, respectively); in samples SE07 and ET171, Q148H (1.1% and 1.2%, respectively); and in sample ET122, M230L (4.8%) were reported by MiDRM<italic>pol</italic> but not by PASeq. This is possibly because of the FastUniq tool used in MiDRM<italic>pol</italic>, which removes duplicate reads, due to which the minor populations of mutations are enriched. </p>
      <p>In sample 24C, T215A (99.7%) and T69N (41.7%) were not detected in our pipeline because we do not consider T215A and T69N as resistance mutations against any of the RTIs. One of the mutations (D67E) was detected at 77.1% in PASeq but not detected in our pipeline.</p>
    </sec>
  </sec>
  <sec sec-type="discussion" id="sec4-viruses-11-00806">
    <title>4. Discussion</title>
    <p>In this study, our in-house pipeline, MiDRM<italic>pol</italic>, was evaluated for the identification of DRMs in sequences obtained by HTS. Patients from Swedish, Indian, and Ethiopian cohorts, representing diverse subtypes, were included. The MiDRM<italic>pol</italic> pipeline was successful in detecting all major and minor DRMs. Identification of mutations such as M184I, which appears at the very early stage of the evolution of M184V, and T215S, a revertant mutation, by GRT-HTS shows that it can detect the early evolution of DRM and earlier exposure of cART, which can provide further information about, for example, pretreatment drug resistance (PDR) in global surveillances of the spread of resistant HIV-1. Although GRT-HTS detects HIV DRMs more sensitively than GRT-PS, the generalized application of such methods for clinical DR monitoring is not currently feasible due to the high cost per sample. However, the cost per megabase of raw data of DNA sequences has decreased 370-fold, from US$5.200 in 2001, to US$0.014 in 2015 [<xref rid="B17-viruses-11-00806" ref-type="bibr">17</xref>]. Equipment and maintenance costs, however, remain unaffordable for many low-income countries. The most important limitation, however, is the lack of automated, validated, and robust but simplified bioinformatic analyses coupled with HIV-1 resistance interpretations to enable NGS use and interpretation by laboratory technicians, but even this is improving rapidly [<xref rid="B18-viruses-11-00806" ref-type="bibr">18</xref>]. Currently, for our approach, the cost per sample was US$130–US$150 when 24 samples were pooled in a single run [<xref rid="B5-viruses-11-00806" ref-type="bibr">5</xref>]. This can be further reduced by multiplexing a higher number of samples. MiDRM<italic>pol</italic> would cut the costs down by excluding the necessity of bioinformaticians to analyze HTS data. </p>
    <p>DRMs were identified 8 times more often by GRT-HTS than by GRT-PS, which is in agreement with another study, which observed that 30%–50% of transmitted drug resistance (TDR) mutations were not identified by GRT-PS [<xref rid="B19-viruses-11-00806" ref-type="bibr">19</xref>,<xref rid="B20-viruses-11-00806" ref-type="bibr">20</xref>]. An investigation of the established pipelines PASeq and HyDRA showed minimal advantage when using HTS data over Sanger sequencing in identifying low-frequency DRMs (≥5%) in virological failure individuals treated with integrase inhibitors [<xref rid="B21-viruses-11-00806" ref-type="bibr">21</xref>]. In our earlier study of an Ethiopian cohort, we identified an increased risk of treatment failure in patients who had pretherapy minor RTI mutations [<xref rid="B22-viruses-11-00806" ref-type="bibr">22</xref>]. To the best of our knowledge, no bioinformatics pipeline interprets the success of ART. It is important that the outcome of the result generated through the pipeline is used to predict the treatment outcomes and guide patient management in clinical practice [<xref rid="B23-viruses-11-00806" ref-type="bibr">23</xref>]. The impact of drug-resistant variants does not depend only on the frequency; rather, the mutational load (Equation (1)) determines more precisely the absolute burden of the resistant variants [<xref rid="B24-viruses-11-00806" ref-type="bibr">24</xref>,<xref rid="B25-viruses-11-00806" ref-type="bibr">25</xref>]. Thus, at a high viral load, even &lt;1% of minor NNRTI DRM variants have been claimed to have the potential to overcome the drug pressure [<xref rid="B26-viruses-11-00806" ref-type="bibr">26</xref>,<xref rid="B27-viruses-11-00806" ref-type="bibr">27</xref>].
<disp-formula id="FD1-viruses-11-00806"><label>(1)</label><mml:math id="mm1"><mml:mrow><mml:mrow><mml:mi>M</mml:mi><mml:mi>u</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>o</mml:mi><mml:mi>n</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>l</mml:mi><mml:mtext> </mml:mtext><mml:mi>l</mml:mi><mml:mi>o</mml:mi><mml:mi>a</mml:mi><mml:mi>d</mml:mi><mml:mtext> </mml:mtext><mml:mo>=</mml:mo><mml:mtext> </mml:mtext><mml:mi>H</mml:mi><mml:mi>I</mml:mi><mml:mi>V</mml:mi><mml:mtext> </mml:mtext><mml:mi>R</mml:mi><mml:mi>N</mml:mi><mml:mi>A</mml:mi><mml:mtext> </mml:mtext><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>p</mml:mi><mml:mi>i</mml:mi><mml:mi>e</mml:mi><mml:mi>s</mml:mi><mml:mtext> </mml:mtext><mml:mi>p</mml:mi><mml:mi>e</mml:mi><mml:mi>r</mml:mi><mml:mtext> </mml:mtext><mml:mi>m</mml:mi><mml:mi>L</mml:mi><mml:mtext> </mml:mtext><mml:mo>×</mml:mo><mml:mi>M</mml:mi><mml:mi>u</mml:mi><mml:mi>t</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mtext> </mml:mtext><mml:mi>v</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>i</mml:mi><mml:mi>a</mml:mi><mml:mi>n</mml:mi><mml:mi>t</mml:mi><mml:mtext> </mml:mtext><mml:mi>f</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi><mml:mi>q</mml:mi><mml:mi>u</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mi>c</mml:mi><mml:mi>y</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:mrow></mml:math></disp-formula></p>
    <p>However, the pipeline MiDRM<italic>pol</italic> was designed to identify &gt;1% of minor DRM populations, independent of the subtype. Although 10 of the patients from Sweden were treatment experienced, only 2 of them claimed to be undergoing treatment but had most likely not taken the drugs. Only 3 of the 10 patients had detectable DRMs despite earlier treatment failures. It should, however, be noted that ART had been terminated just a few months before sampling, suggesting that the DRMs had not yet had time to disappear. In other patients, the treatment had been terminated several months or years before. Thus, although no precise analysis can be done due to lack of samples during earlier treatment failure, our data indicate that even the use of a very sensitive HTS may fail to detect DRMs which had developed at earlier treatment failures. </p>
    <p>In the Indian cohort, we identified minor DRMs in 2 out of 10 treatment-naïve individuals who were vertically infected. Eight minor RTI DRMs, including K65R (3.0%), M184V (7.5%), and V106M (3.9%), were detected in one infant (IN07), as a result of the transmission of the resistant virus from the mother. Thus, our data show that GRT-HTS improves detection of vertically transmitted DRMs in infants [<xref rid="B28-viruses-11-00806" ref-type="bibr">28</xref>]. </p>
    <p>Similar algorithms for determining the frequency of DRM variants are available, for example, PASeq [<xref rid="B29-viruses-11-00806" ref-type="bibr">29</xref>], a web service which uses various tools, and CoVaMa (Co-Variation Mapper), which is scripted in Python and takes HTS alignment data and populates large matrices of contingency tables [<xref rid="B30-viruses-11-00806" ref-type="bibr">30</xref>]. Other available automated pipelines for analysis of sequences obtained through HTS have been summarized in a comparative study [<xref rid="B31-viruses-11-00806" ref-type="bibr">31</xref>]. We compared our pipeline with PASeq and observed concordance at the DRM level, although our pipeline also detected M184I mutations in treatment-naïve individuals at minor populations. </p>
  </sec>
  <sec sec-type="conclusions" id="sec5-viruses-11-00806">
    <title>5. Conclusions</title>
    <p>In this study, we developed an efficient and simplified high-throughput amplicon sequence analysis pipeline named MiDRM<italic>pol</italic>, which does not require onsite bioinformatics expertise. This pipeline can detect minor DRMs in viral populations at a &gt;1% cutoff and was successfully evaluated in three cohorts consisting of various subtypes. The reliability was analyzed by comparing the sequences generated through both GRT-HTS and GRT-PS. In all of our cohorts, MiDRM<italic>pol</italic> identified DRMs against the three drug classes in minor viral quasi-species at analysis of sequences obtained through HTS. The complete script is available at GitHub at <uri xlink:href="https://github.com/neogilab/MiDRMPol">https://github.com/neogilab/MiDRMPol</uri>. Our simplified online pipeline for HTS data of the HIV-1 <italic>pol</italic> gene would be a valuable tool in the use of diagnostics of drug resistance variants before initiation of ART and after ART failure in optimizing subsequent regimens. </p>
  </sec>
</body>
<back>
  <ack>
    <title>Acknowledgments</title>
    <p>The following reagent was obtained through the NIH AIDS Reagent Program, Division of AIDS, NIAID, NIH: HIV-1 MJ4 Infectious Molecular Clone (pMJ4) from Drs. Thumbi Ndung’u, Boris Renjifo, and Max Essex. M.A. would like to acknowledge ICMR, India for providing the senior research fellowship. </p>
  </ack>
  <notes>
    <title>Author Contributions</title>
    <p>Conceptualization, U.N.; methodology, U.N., S.G.A., and M.A.; software, A.T.A. and M.M.K.; validation, S.G.A., M.A., and A.T.A.; formal analysis, U.N., S.G.A., and A.T.A.; investigation, S.G.A. and M.A.; resources, L.E.H., W.A., and A.S.; data curation, A.T.A.; writing—original draft preparation, S.G.A.; writing—review and editing, S.G.A., A.T.A., M.A., M.M.K., L.E.H., W.A., A.S., and U.N.; visualization, S.G.A., A.T.A., and U.N.; supervision, U.N.; project administration, U.N.; funding acquisition, U.N.</p>
  </notes>
  <notes>
    <title>Funding</title>
    <p>The study was funded by the Swedish Research Council (2017-01330, UN; 2016-01675, AS), Karolinska Institutet Doctoral Student Funding (KID2015-154), the European Union´s Horizon 2020 research and innovation program under grant agreement no. 825673, and the Stockholm County Council (ALF 20160074, AS).</p>
  </notes>
  <notes notes-type="COI-statement">
    <title>Conflicts of Interest</title>
    <p>The authors declare no conflict of interest.</p>
  </notes>
  <ref-list>
    <title>References</title>
    <ref id="B1-viruses-11-00806">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Inzaule</surname>
            <given-names>S.C.</given-names>
          </name>
          <name>
            <surname>Hamers</surname>
            <given-names>R.L.</given-names>
          </name>
          <name>
            <surname>Noguera-Julian</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Casadella</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Parera</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Kityo</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Steegen</surname>
            <given-names>K.</given-names>
          </name>
          <name>
            <surname>Naniche</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Clotet</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Rinke de Wit</surname>
            <given-names>T.F.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Clinically relevant thresholds for ultrasensitive hiv drug resistance testing: A multi-country nested case-control study</article-title>
        <source>Lancet HIV</source>
        <year>2018</year>
        <volume>5</volume>
        <fpage>e638</fpage>
        <lpage>e646</lpage>
        <pub-id pub-id-type="doi">10.1016/S2352-3018(18)30177-2</pub-id>
        <pub-id pub-id-type="pmid">30282603</pub-id>
      </element-citation>
    </ref>
    <ref id="B2-viruses-11-00806">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Posada-Cespedes</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Seifert</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Beerenwinkel</surname>
            <given-names>N.</given-names>
          </name>
        </person-group>
        <article-title>Recent advances in inferring viral diversity from high-throughput sequencing data</article-title>
        <source>Virus Res.</source>
        <year>2017</year>
        <volume>239</volume>
        <fpage>17</fpage>
        <lpage>32</lpage>
        <pub-id pub-id-type="doi">10.1016/j.virusres.2016.09.016</pub-id>
        <?supplied-pmid 27693290?>
        <pub-id pub-id-type="pmid">27693290</pub-id>
      </element-citation>
    </ref>
    <ref id="B3-viruses-11-00806">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ji</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Enns</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Brumme</surname>
            <given-names>C.J.</given-names>
          </name>
          <name>
            <surname>Parkin</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Howison</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>E.R.</given-names>
          </name>
          <name>
            <surname>Capina</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Marinier</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Avila-Rios</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Sandstrom</surname>
            <given-names>P.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Bioinformatic data processing pipelines in support of next-generation sequencing-based hiv drug resistance testing: The winnipeg consensus</article-title>
        <source>J. Int. AIDS Soc.</source>
        <year>2018</year>
        <volume>21</volume>
        <fpage>e25193</fpage>
        <pub-id pub-id-type="doi">10.1002/jia2.25193</pub-id>
        <?supplied-pmid 30350345?>
        <pub-id pub-id-type="pmid">30350345</pub-id>
      </element-citation>
    </ref>
    <ref id="B4-viruses-11-00806">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ndung’u</surname>
            <given-names>T.</given-names>
          </name>
          <name>
            <surname>Renjifo</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Essex</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Construction and analysis of an infectious human immunodeficiency virus type 1 subtype c molecular clone</article-title>
        <source>J. Virol.</source>
        <year>2001</year>
        <volume>75</volume>
        <fpage>4964</fpage>
        <lpage>4972</lpage>
        <pub-id pub-id-type="doi">10.1128/JVI.75.11.4964-4972.2001</pub-id>
        <?supplied-pmid 11333875?>
        <pub-id pub-id-type="pmid">11333875</pub-id>
      </element-citation>
    </ref>
    <ref id="B5-viruses-11-00806">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Aralaguppe</surname>
            <given-names>S.G.</given-names>
          </name>
          <name>
            <surname>Siddik</surname>
            <given-names>A.B.</given-names>
          </name>
          <name>
            <surname>Manickam</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Ambikan</surname>
            <given-names>A.T.</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>M.M.</given-names>
          </name>
          <name>
            <surname>Fernandes</surname>
            <given-names>S.J.</given-names>
          </name>
          <name>
            <surname>Amogne</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Bangaruswamy</surname>
            <given-names>D.K.</given-names>
          </name>
          <name>
            <surname>Hanna</surname>
            <given-names>L.E.</given-names>
          </name>
          <name>
            <surname>Sonnerborg</surname>
            <given-names>A.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Multiplexed next-generation sequencing and de novo assembly to obtain near full-length hiv-1 genome from plasma virus</article-title>
        <source>J. Virol. Methods</source>
        <year>2016</year>
        <volume>236</volume>
        <fpage>98</fpage>
        <lpage>104</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jviromet.2016.07.010</pub-id>
        <?supplied-pmid 27448822?>
        <pub-id pub-id-type="pmid">27448822</pub-id>
      </element-citation>
    </ref>
    <ref id="B6-viruses-11-00806">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Martin</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Cutadapt removes adapter sequences from high-throughput sequencing reads</article-title>
        <source>EMBnet. J.</source>
        <year>2011</year>
        <volume>17</volume>
        <fpage>10</fpage>
        <lpage>12</lpage>
        <pub-id pub-id-type="doi">10.14806/ej.17.1.200</pub-id>
      </element-citation>
    </ref>
    <ref id="B7-viruses-11-00806">
      <label>7.</label>
      <element-citation publication-type="web">
        <person-group person-group-type="author">
          <name>
            <surname>Joshi</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Fass</surname>
            <given-names>J.</given-names>
          </name>
        </person-group>
        <article-title>Sickle: A sliding-window, adaptive, quality-based trimming tool for fastq files (version 1.33) [software]</article-title>
        <year>2011</year>
        <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://github.com/najoshi/sickle">https://github.com/najoshi/sickle</ext-link></comment>
        <date-in-citation content-type="access-date" iso-8601-date="2019-01-02">(accessed on 2 January 2019)</date-in-citation>
      </element-citation>
    </ref>
    <ref id="B8-viruses-11-00806">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Luo</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Pang</surname>
            <given-names>X.</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>S.</given-names>
          </name>
        </person-group>
        <article-title>Fastuniq: A fast <italic>de novo</italic> duplicates removal tool for paired short reads</article-title>
        <source>PLoS ONE</source>
        <year>2012</year>
        <volume>7</volume>
        <elocation-id>e52249</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0052249</pub-id>
        <?supplied-pmid 23284954?>
        <pub-id pub-id-type="pmid">23284954</pub-id>
      </element-citation>
    </ref>
    <ref id="B9-viruses-11-00806">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Langmead</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Salzberg</surname>
            <given-names>S.L.</given-names>
          </name>
        </person-group>
        <article-title>Fast gapped-read alignment with bowtie 2</article-title>
        <source>Nat Methods</source>
        <year>2012</year>
        <volume>9</volume>
        <fpage>357</fpage>
        <lpage>359</lpage>
        <pub-id pub-id-type="doi">10.1038/nmeth.1923</pub-id>
        <?supplied-pmid 22388286?>
        <pub-id pub-id-type="pmid">22388286</pub-id>
      </element-citation>
    </ref>
    <ref id="B10-viruses-11-00806">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Altschul</surname>
            <given-names>S.F.</given-names>
          </name>
          <name>
            <surname>Gish</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Myers</surname>
            <given-names>E.W.</given-names>
          </name>
          <name>
            <surname>Lipman</surname>
            <given-names>D.J.</given-names>
          </name>
        </person-group>
        <article-title>Basic local alignment search tool</article-title>
        <source>J. Mol. Biol.</source>
        <year>1990</year>
        <volume>215</volume>
        <fpage>403</fpage>
        <lpage>410</lpage>
        <pub-id pub-id-type="doi">10.1016/S0022-2836(05)80360-2</pub-id>
        <pub-id pub-id-type="pmid">2231712</pub-id>
      </element-citation>
    </ref>
    <ref id="B11-viruses-11-00806">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Amogne</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Bontell</surname>
            <given-names>I.</given-names>
          </name>
          <name>
            <surname>Grossmann</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Aderaye</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Lindquist</surname>
            <given-names>L.</given-names>
          </name>
          <name>
            <surname>Sonnerborg</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Neogi</surname>
            <given-names>U.</given-names>
          </name>
        </person-group>
        <article-title>Phylogenetic analysis of ethiopian hiv-1 subtype c near full-length genomes reveals high intrasubtype diversity and a strong geographical cluster</article-title>
        <source>AIDS Res. Hum. Retroviruses</source>
        <year>2016</year>
        <volume>32</volume>
        <fpage>471</fpage>
        <lpage>474</lpage>
        <pub-id pub-id-type="doi">10.1089/aid.2015.0380</pub-id>
        <pub-id pub-id-type="pmid">26881451</pub-id>
      </element-citation>
    </ref>
    <ref id="B12-viruses-11-00806">
      <label>12.</label>
      <element-citation publication-type="web">
        <article-title>Regav3</article-title>
        <comment>Available online: <ext-link ext-link-type="uri" xlink:href="http://dbpartners.stanford.edu:8080/RegaSubtyping/stanford-hiv/typingtool/">http://dbpartners.stanford.edu:8080/RegaSubtyping/stanford-hiv/typingtool/</ext-link></comment>
        <date-in-citation content-type="access-date" iso-8601-date="2016-03-30">(accessed on 30 March 2016)</date-in-citation>
      </element-citation>
    </ref>
    <ref id="B13-viruses-11-00806">
      <label>13.</label>
      <element-citation publication-type="web">
        <article-title>Comet-HIV</article-title>
        <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://comet.lih.lu/">https://comet.lih.lu/</ext-link></comment>
        <date-in-citation content-type="access-date" iso-8601-date="2016-03-30">(accessed on 30 March 2016)</date-in-citation>
      </element-citation>
    </ref>
    <ref id="B14-viruses-11-00806">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bennett</surname>
            <given-names>D.E.</given-names>
          </name>
          <name>
            <surname>Camacho</surname>
            <given-names>R.J.</given-names>
          </name>
          <name>
            <surname>Otelea</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Kuritzkes</surname>
            <given-names>D.R.</given-names>
          </name>
          <name>
            <surname>Fleury</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Kiuchi</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Heneine</surname>
            <given-names>W.</given-names>
          </name>
          <name>
            <surname>Kantor</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Jordan</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Schapiro</surname>
            <given-names>J.M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Drug resistance mutations for surveillance of transmitted hiv-1 drug-resistance: 2009 update</article-title>
        <source>PLoS ONE</source>
        <year>2009</year>
        <volume>4</volume>
        <elocation-id>e4724</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0004724</pub-id>
        <?supplied-pmid 19266092?>
        <pub-id pub-id-type="pmid">19266092</pub-id>
      </element-citation>
    </ref>
    <ref id="B15-viruses-11-00806">
      <label>15.</label>
      <element-citation publication-type="web">
        <article-title>Stanford hiv db</article-title>
        <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://hivdb.stanford.edu/assets/media/resistance-mutation-handout-Feb2017.516aee6f.pdf">https://hivdb.stanford.edu/assets/media/resistance-mutation-handout-Feb2017.516aee6f.pdf</ext-link></comment>
        <date-in-citation content-type="access-date" iso-8601-date="2018-01-02">(accessed on 2 January 2018)</date-in-citation>
      </element-citation>
    </ref>
    <ref id="B16-viruses-11-00806">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rhee</surname>
            <given-names>S.Y.</given-names>
          </name>
          <name>
            <surname>Gonzales</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Kantor</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Betts</surname>
            <given-names>B.J.</given-names>
          </name>
          <name>
            <surname>Ravela</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Shafer</surname>
            <given-names>R.W.</given-names>
          </name>
        </person-group>
        <article-title>Human immunodeficiency virus reverse transcriptase and protease sequence database</article-title>
        <source>Nucleic Acids Res.</source>
        <year>2003</year>
        <volume>31</volume>
        <fpage>298</fpage>
        <lpage>303</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkg100</pub-id>
        <?supplied-pmid 12520007?>
        <pub-id pub-id-type="pmid">12520007</pub-id>
      </element-citation>
    </ref>
    <ref id="B17-viruses-11-00806">
      <label>17.</label>
      <element-citation publication-type="gov">
        <article-title>DNA sequencing costs: Data from the nhgri genome sequencing program (gsp)</article-title>
        <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.genome.gov/about-genomics/fact-sheets/DNA-Sequencing-Costs-Data">https://www.genome.gov/about-genomics/fact-sheets/DNA-Sequencing-Costs-Data</ext-link></comment>
        <date-in-citation content-type="access-date" iso-8601-date="2019-08-13">(accessed on 13 August 2019)</date-in-citation>
      </element-citation>
    </ref>
    <ref id="B18-viruses-11-00806">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Casadella</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Paredes</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>Deep sequencing for hiv-1 clinical management</article-title>
        <source>Virus Res.</source>
        <year>2017</year>
        <volume>239</volume>
        <fpage>69</fpage>
        <lpage>81</lpage>
        <pub-id pub-id-type="doi">10.1016/j.virusres.2016.10.019</pub-id>
        <?supplied-pmid 27818211?>
        <pub-id pub-id-type="pmid">27818211</pub-id>
      </element-citation>
    </ref>
    <ref id="B19-viruses-11-00806">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ekici</surname>
            <given-names>H.</given-names>
          </name>
          <name>
            <surname>Rao</surname>
            <given-names>S.D.</given-names>
          </name>
          <name>
            <surname>Sonnerborg</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Ramprasad</surname>
            <given-names>V.L.</given-names>
          </name>
          <name>
            <surname>Gupta</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Neogi</surname>
            <given-names>U.</given-names>
          </name>
        </person-group>
        <article-title>Cost-efficient hiv-1 drug resistance surveillance using multiplexed high-throughput amplicon sequencing: Implications for use in low- and middle-income countries</article-title>
        <source>J. Antimicrob. Chemother.</source>
        <year>2014</year>
        <volume>69</volume>
        <fpage>3349</fpage>
        <lpage>3355</lpage>
        <pub-id pub-id-type="doi">10.1093/jac/dku278</pub-id>
        <?supplied-pmid 25085657?>
        <pub-id pub-id-type="pmid">25085657</pub-id>
      </element-citation>
    </ref>
    <ref id="B20-viruses-11-00806">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Arias</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>López</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Sánchez</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Yamamura</surname>
            <given-names>Y.</given-names>
          </name>
          <name>
            <surname>Rivera-Amill</surname>
            <given-names>V.</given-names>
          </name>
        </person-group>
        <article-title>Sanger and next generation sequencing approaches to evaluate hiv-1 virus in blood compartments</article-title>
        <source>Int. J. Environ. Res. Public Health</source>
        <year>2018</year>
        <volume>15</volume>
        <elocation-id>1697</elocation-id>
        <pub-id pub-id-type="doi">10.3390/ijerph15081697</pub-id>
      </element-citation>
    </ref>
    <ref id="B21-viruses-11-00806">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dalmat</surname>
            <given-names>R.R.</given-names>
          </name>
          <name>
            <surname>Makhsous</surname>
            <given-names>N.</given-names>
          </name>
          <name>
            <surname>Pepper</surname>
            <given-names>G.G.</given-names>
          </name>
          <name>
            <surname>Magaret</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Jerome</surname>
            <given-names>K.R.</given-names>
          </name>
          <name>
            <surname>Wald</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Greninger</surname>
            <given-names>A.L.</given-names>
          </name>
        </person-group>
        <article-title>Limited marginal utility of deep sequencing for hiv drug resistance testing in the age of integrase inhibitors</article-title>
        <source>J. Clin. Microbiol.</source>
        <year>2018</year>
        <volume>56</volume>
        <pub-id pub-id-type="doi">10.1128/JCM.01443-18</pub-id>
      </element-citation>
    </ref>
    <ref id="B22-viruses-11-00806">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Telele</surname>
            <given-names>N.F.</given-names>
          </name>
          <name>
            <surname>Kalu</surname>
            <given-names>A.W.</given-names>
          </name>
          <name>
            <surname>Gebre-Selassie</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Fekade</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Abdurahman</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Marrone</surname>
            <given-names>G.</given-names>
          </name>
          <name>
            <surname>Neogi</surname>
            <given-names>U.</given-names>
          </name>
          <name>
            <surname>Tegbaru</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Sonnerborg</surname>
            <given-names>A.</given-names>
          </name>
        </person-group>
        <article-title>Pretreatment drug resistance in a large countrywide ethiopian hiv-1c cohort: A comparison of sanger and high-throughput sequencing</article-title>
        <source>Sci. Rep.</source>
        <year>2018</year>
        <volume>8</volume>
        <fpage>7556</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-018-25888-6</pub-id>
        <pub-id pub-id-type="pmid">29765082</pub-id>
      </element-citation>
    </ref>
    <ref id="B23-viruses-11-00806">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gianella</surname>
            <given-names>S.</given-names>
          </name>
          <name>
            <surname>Richman</surname>
            <given-names>D.D.</given-names>
          </name>
        </person-group>
        <article-title>Minority variants of drug-resistant hiv</article-title>
        <source>J. Infect. Dis.</source>
        <year>2010</year>
        <volume>202</volume>
        <fpage>657</fpage>
        <lpage>666</lpage>
        <pub-id pub-id-type="doi">10.1086/655397</pub-id>
        <pub-id pub-id-type="pmid">20649427</pub-id>
      </element-citation>
    </ref>
    <ref id="B24-viruses-11-00806">
      <label>24.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kozal</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Chiarella</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>St John</surname>
            <given-names>E.P.</given-names>
          </name>
          <name>
            <surname>Moreno</surname>
            <given-names>E.A.</given-names>
          </name>
          <name>
            <surname>Simen</surname>
            <given-names>B.B.</given-names>
          </name>
          <name>
            <surname>Arnold</surname>
            <given-names>T.E.</given-names>
          </name>
          <name>
            <surname>Lataillade</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Prevalence of low-level hiv-1 variants with reverse transcriptase mutation k65r and the effect of antiretroviral drug exposure on variant levels</article-title>
        <source>Antivir. Ther.</source>
        <year>2011</year>
        <volume>16</volume>
        <fpage>925</fpage>
        <lpage>929</lpage>
        <pub-id pub-id-type="doi">10.3851/IMP1851</pub-id>
        <pub-id pub-id-type="pmid">21900725</pub-id>
      </element-citation>
    </ref>
    <ref id="B25-viruses-11-00806">
      <label>25.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lataillade</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Chiarella</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>DeGrosky</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Uy</surname>
            <given-names>J.</given-names>
          </name>
          <name>
            <surname>Seekins</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Simen</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>St John</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Moreno</surname>
            <given-names>E.</given-names>
          </name>
          <name>
            <surname>Kozal</surname>
            <given-names>M.</given-names>
          </name>
        </person-group>
        <article-title>Virologic failures on initial boosted-pi regimen infrequently possess low-level variants with major pi resistance mutations by ultra-deep sequencing</article-title>
        <source>PLoS ONE</source>
        <year>2012</year>
        <volume>7</volume>
        <elocation-id>e30118</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0030118</pub-id>
        <pub-id pub-id-type="pmid">22355307</pub-id>
      </element-citation>
    </ref>
    <ref id="B26-viruses-11-00806">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>J.Z.</given-names>
          </name>
          <name>
            <surname>Paredes</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Ribaudo</surname>
            <given-names>H.J.</given-names>
          </name>
          <name>
            <surname>Svarovskaia</surname>
            <given-names>E.S.</given-names>
          </name>
          <name>
            <surname>Metzner</surname>
            <given-names>K.J.</given-names>
          </name>
          <name>
            <surname>Kozal</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Hullsiek</surname>
            <given-names>K.H.</given-names>
          </name>
          <name>
            <surname>Balduin</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Jakobsen</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Geretti</surname>
            <given-names>A.M.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Low-frequency hiv-1 drug resistance mutations and risk of nnrti-based antiretroviral treatment failure: A systematic review and pooled analysis</article-title>
        <source>JAMA J. Am. Med Assoc.</source>
        <year>2011</year>
        <volume>305</volume>
        <fpage>1327</fpage>
        <lpage>1335</lpage>
        <pub-id pub-id-type="doi">10.1001/jama.2011.375</pub-id>
        <?supplied-pmid 21467286?>
        <pub-id pub-id-type="pmid">21467286</pub-id>
      </element-citation>
    </ref>
    <ref id="B27-viruses-11-00806">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>J.Z.</given-names>
          </name>
          <name>
            <surname>Paredes</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Ribaudo</surname>
            <given-names>H.J.</given-names>
          </name>
          <name>
            <surname>Kozal</surname>
            <given-names>M.J.</given-names>
          </name>
          <name>
            <surname>Svarovskaia</surname>
            <given-names>E.S.</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>J.A.</given-names>
          </name>
          <name>
            <surname>Geretti</surname>
            <given-names>A.M.</given-names>
          </name>
          <name>
            <surname>Metzner</surname>
            <given-names>K.J.</given-names>
          </name>
          <name>
            <surname>Jakobsen</surname>
            <given-names>M.R.</given-names>
          </name>
          <name>
            <surname>Hullsiek</surname>
            <given-names>K.H.</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Impact of minority nonnucleoside reverse transcriptase inhibitor resistance mutations on resistance genotype after virologic failure</article-title>
        <source>J. Infect. Dis.</source>
        <year>2013</year>
        <volume>207</volume>
        <fpage>893</fpage>
        <lpage>897</lpage>
        <pub-id pub-id-type="doi">10.1093/infdis/jis925</pub-id>
        <?supplied-pmid 23264671?>
        <pub-id pub-id-type="pmid">23264671</pub-id>
      </element-citation>
    </ref>
    <ref id="B28-viruses-11-00806">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fisher</surname>
            <given-names>R.G.</given-names>
          </name>
          <name>
            <surname>Smith</surname>
            <given-names>D.M.</given-names>
          </name>
          <name>
            <surname>Murrell</surname>
            <given-names>B.</given-names>
          </name>
          <name>
            <surname>Slabbert</surname>
            <given-names>R.</given-names>
          </name>
          <name>
            <surname>Kirby</surname>
            <given-names>B.M.</given-names>
          </name>
          <name>
            <surname>Edson</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Cotton</surname>
            <given-names>M.F.</given-names>
          </name>
          <name>
            <surname>Haubrich</surname>
            <given-names>R.H.</given-names>
          </name>
          <name>
            <surname>Kosakovsky Pond</surname>
            <given-names>S.L.</given-names>
          </name>
          <name>
            <surname>Van Zyl</surname>
            <given-names>G.U.</given-names>
          </name>
        </person-group>
        <article-title>Next generation sequencing improves detection of drug resistance mutations in infants after pmtct failure</article-title>
        <source>J. Clin. Virol.</source>
        <year>2015</year>
        <volume>62</volume>
        <fpage>48</fpage>
        <lpage>53</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jcv.2014.11.014</pub-id>
        <?supplied-pmid 25542470?>
        <pub-id pub-id-type="pmid">25542470</pub-id>
      </element-citation>
    </ref>
    <ref id="B29-viruses-11-00806">
      <label>29.</label>
      <element-citation publication-type="web">
        <comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.paseq.org/">https://www.paseq.org/</ext-link></comment>
        <date-in-citation content-type="access-date" iso-8601-date="2019-01-02">(accessed on 2 January 2019)</date-in-citation>
      </element-citation>
    </ref>
    <ref id="B30-viruses-11-00806">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Routh</surname>
            <given-names>A.</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>M.W.</given-names>
          </name>
          <name>
            <surname>Okulicz</surname>
            <given-names>J.F.</given-names>
          </name>
          <name>
            <surname>Johnson</surname>
            <given-names>J.E.</given-names>
          </name>
          <name>
            <surname>Torbett</surname>
            <given-names>B.E.</given-names>
          </name>
        </person-group>
        <article-title>Covama: Co-variation mapper for disequilibrium analysis of mutant loci in viral populations using next-generation sequence data</article-title>
        <source>Methods</source>
        <year>2015</year>
        <volume>91</volume>
        <fpage>40</fpage>
        <lpage>47</lpage>
        <pub-id pub-id-type="doi">10.1016/j.ymeth.2015.09.021</pub-id>
        <?supplied-pmid 26408523?>
        <pub-id pub-id-type="pmid">26408523</pub-id>
      </element-citation>
    </ref>
    <ref id="B31-viruses-11-00806">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Noguera-Julian</surname>
            <given-names>M.</given-names>
          </name>
          <name>
            <surname>Edgil</surname>
            <given-names>D.</given-names>
          </name>
          <name>
            <surname>Harrigan</surname>
            <given-names>P.R.</given-names>
          </name>
          <name>
            <surname>Sandstrom</surname>
            <given-names>P.</given-names>
          </name>
          <name>
            <surname>Godfrey</surname>
            <given-names>C.</given-names>
          </name>
          <name>
            <surname>Paredes</surname>
            <given-names>R.</given-names>
          </name>
        </person-group>
        <article-title>Next-generation human immunodeficiency virus sequencing for patient management and drug resistance surveillance</article-title>
        <source>J. Infect. Dis.</source>
        <year>2017</year>
        <volume>216</volume>
        <fpage>S829</fpage>
        <lpage>S833</lpage>
        <pub-id pub-id-type="doi">10.1093/infdis/jix397</pub-id>
        <?supplied-pmid 28968834?>
        <pub-id pub-id-type="pmid">28968834</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
<floats-group>
  <fig id="viruses-11-00806-f001" orientation="portrait" position="float">
    <label>Figure 1</label>
    <caption>
      <p>Coverage plot and error calculation: (<bold>a</bold>) The median coverage in each of the positions is indicated by the a dark green line. The light-green shade is the range of the coverage. (<bold>b</bold>) The error was calculated from the amino acid sequences of pMJ4 (NCBI# AF321523). Red dots indicate the drug resistance mutation (DRM) positions.</p>
    </caption>
    <graphic xlink:href="viruses-11-00806-g001"/>
  </fig>
  <fig id="viruses-11-00806-f002" orientation="portrait" position="float">
    <label>Figure 2</label>
    <caption>
      <p>The phylogenetic analysis of the gag-pol sequences. A total of 100 sequences were used in the analysis (87 samples and 13 consensus sequences of gag-vpu from diverse HIV-1 subtypes downloaded from HIVdb). Green circles represent the Swedish cohort (<italic>n</italic> = 60), blue triangles represent the Indian cohort (<italic>n</italic> = 10), and red squares represent the Ethiopian cohort (<italic>n</italic> = 17). The reference sequences of gag-pol from various genetic subtypes—A1, A2, B, C, D, F1, F2, G, H, AE, and AG—were downloaded from the Los Alamos HIV database. After gap-stripping, there were a total of 3096 nucleic acid positions in the final dataset. The bootstrap consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analyzed. The tree was drawn to scale, with branch lengths in the same units as those of the evolutionary distances used to infer the phylogenetic tree. The evolutionary distances were computed using the maximum composite likelihood method and are in the units of the number of base substitutions per site.</p>
    </caption>
    <graphic xlink:href="viruses-11-00806-g002"/>
  </fig>
  <table-wrap id="viruses-11-00806-t001" orientation="portrait" position="float">
    <object-id pub-id-type="pii">viruses-11-00806-t001_Table 1</object-id>
    <label>Table 1</label>
    <caption>
      <p>Comparison of DRMs identified by high-throughput sequencing or population sequencing as well as in PASeq and MiDRM<italic>pol</italic> outputs.</p>
    </caption>
    <table frame="hsides" rules="groups">
      <thead>
        <tr>
          <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Cohort</th>
          <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">PID</th>
          <th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">Treatment</th>
          <th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">MiDRM<italic>pol</italic></th>
          <th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">PASeq</th>
          <th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">GRT-PS</th>
        </tr>
        <tr>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PI</th>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NRTI</th>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NNRTI</th>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INI</th>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PI</th>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NRTI</th>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NNRTI</th>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">INI</th>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NRTI</th>
          <th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NNRTI</th>
        </tr>
      </thead>
      <tbody>
        <tr>
          <td rowspan="19" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
            <bold>Swedish</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>SE03</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Experienced</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>D67G (2.0%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K103R (16.9%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L74I (1.9%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>SE70</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Experienced</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>D67N (99.7%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K103N (99.8%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>D67N (99.9%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K103N (99.9%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>D67N</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K103N</bold>
          </td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L210W (99.5%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>G190A (99.6%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L210W (99.8%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>G190A (99.7%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L210W</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>G190A</bold>
          </td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T215Y (99.4%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T215Y (99.8%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T215Y</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>SE73</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Experienced</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>D67N (44.2%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K103N (95.9%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>D67N (49.2%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K103N (96.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K103N</bold>
          </td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L210W (23.4%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>G190A (35.2%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L210W (46.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>G190A (49.6%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>Y188C</bold>
          </td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T215Y (19.7%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T215Y (45.9%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>19C</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M46I (4.6%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td colspan="4" align="center" valign="middle" rowspan="1">Failed</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>20C</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T215S (2.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td colspan="4" align="center" valign="middle" rowspan="1">Failed</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>26C</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M184I (1.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td colspan="4" align="center" valign="middle" rowspan="1">Failed</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>05C</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K219R (2.3%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td colspan="4" align="center" valign="middle" rowspan="1">Failed</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>SE07</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>Q148H (1.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>SE14</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>E138K (5.5%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>E138K (1.6%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>SE31</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M46I (30.2%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M46I (28.9%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>SE97</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>D30N (13.7%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>D30N (12.2%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>24C</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T69D (99.7%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M230L (99.7%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>D67E (77.2%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M230L (99.8%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T69D</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M230L</bold>
          </td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T69D (98.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
            <bold>T215A (99.4%)</bold>
          </td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td rowspan="11" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
            <bold>Indian</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>IN04</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K101E (99.7%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K101E (99.9%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>IN05</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>V75M (7.8%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>V75M (8.6%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>IN06</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>V106M (98.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>V106M (100.0%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>Y181C (22.8%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>Y181C (23.6%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>IN07</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K65R (3.0%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>V106M (3.9%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K65R (2.8%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>V106M (3.6%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">NA</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K70E (3.4%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>G190S (95.6%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>K70E (3.2%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>G190S (96.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L74V (66.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L74V (67.6%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M184V (7.5%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M184V (8.4%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M184I (3.7%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M184I (3.2%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T215I (3.4%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T215I (3.3%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
            <bold>IN08</bold>
          </td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
            <bold>Y181C (99.5%)</bold>
          </td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
            <bold>Y181C (99.9%)</bold>
          </td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td>
        </tr>
        <tr>
          <td rowspan="6" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">
            <bold>Ethiopian</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>ET160</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L76V (4.5%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>L76V (4.4%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>ET115</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M184I (1.1%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>ET122</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M230L (4.8%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>ET155</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T66I (3.3%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>T66I (5.8%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>ET159</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">
            <bold>M184I (1.0%)</bold>
          </td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" rowspan="1" colspan="1">None</td>
        </tr>
        <tr>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
            <bold>ET171</bold>
          </td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Naïve</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
            <bold>M184I (1.5%)</bold>
          </td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
            <bold>Q148H (1.2%)</bold>
          </td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
          <td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">None</td>
        </tr>
      </tbody>
    </table>
    <table-wrap-foot>
      <fn>
        <p>None → no DRM detected; Failed → failure due to upload limit of HTS file; NA → not available.</p>
      </fn>
    </table-wrap-foot>
  </table-wrap>
</floats-group>
